Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension
- Pulmonary Hypertension Complicating Systemic Hypertension, Is Diastolic Dysfunction the Culprit? Dusaj, Raman S.; Mukherjee, Monica; Furmark, Lena; Katz, Richard J.; Choi, Brian G.; Lewis, Jannet F. // Research Journal of Cardiology;Jan-Mar2014, Vol. 2 Issue 1, p1
Background: Elevation in PA pressures has been observed by 2D echo in some but not all hypertensive patients. The mechanism and hemodynamic impact of pulmonary hypertension in these patients remains unclear. Methods: We reviewed echoes of all patients referred with systemic hypertension between...
- Reflections on the Scientific Sessions. // Advances in Pulmonary Hypertension;2014, Vol. 13 Issue 3, p141
Information about topics discussed at a roundtable on the highlights of the International Pulmonary Hypertension Conference and Scientific Sessions held in Indianapolis, Indiana on June 20-22, 2014 is presented. The topics of the roundtable include hemodynamics, pulmonary artery hypertension...
- A low resting heart rate at diagnosis predicts favourable long-term outcome in pulmonary arterial and chronic thromboembolic pulmonary hypertension. A prospective observational study. Hildenbrand, Florian F.; Fauchère, Ivan; Huber, Lars C.; Keusch, Stephan; Speich, Rudolf; Ulrich, Silvia // Respiratory Research;Sep2012, Vol. 13 Issue 9, p1
Background: A low resting heart rate (HR) is prognostically favourable in healthy individuals and in patients with left heart disease. In this study we investigated the impact of HR at diagnosis on long-term outcome in patients with differently classified precapillary pulmonary hypertension...
- Epidemiology. // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 3, p86
The article presents abstracts on medical topics which include the existence of pulmonary arterial hypertension (PAH) in dasatinib treated patients, the impact of air travel on pulmonary hypertensive patients and the Registry to Evaluate Early and Long-Term (REVEAL) PAH in disease management.
- The impact of pulmonary arterial pressure on exercise capacity in mild-to-moderate cystic fibrosis: a case control study. // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 4, p133
The article focuses on a case control study which explores the impact of post-exercise pulmonary artery systolic pressure (PASP) on patients with mild-to moderate cystic fibrosis (CF). It suggests higher post-exercise (PASP) among CF patients without pulmonary hypertension (PH) at rest....
- Insights From the Fifth World Health Organization Symposium Working Group: Definitions and Diagnosis of Pulmonary Hypertension. Torres, Fernando // Advances in Pulmonary Hypertension;2014, Vol. 13 Issue 1, p27
During the Fifth World Symposium on Pulmonary Hypertension, the working group on diagnosis and assessment was charged with evaluating the definition of pulmonary arterial hypertension (PAH) as it was established at the Fourth World Symposium. The group also covered related topics such as...
- Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Mainguy, Vincent; Maltais, François; Saey, Didier; Gagnon, Philippe; Martel, Simon; Simon, Mathieu; Provencher, Steeve // Thorax;Feb2010, Vol. 65 Issue 2, p113
Background A majority of patients with idiopathic pulmonary arterial hypertension (IPAH) display persistent exercise intolerance despite new specific therapies. Whether patients with IPAH exhibit peripheral muscle dysfunction that may contribute to this limitation remains unknown. The hypothesis...
- Chronic Thrombotic Obstruction of Major Pulmonary Arteries. Moser, Kenneth M.; Spragg, Roger G.; Utley, Joseph; Daily, Pat O. // Annals of Internal Medicine;Sep83, Vol. 99 Issue 3, p299
Examines patients with pulmonary hypertension associated with chronic thrombotic obstruction of major pulmonary arteries. Clinical features of patients with pulmonary hypertension; Diagnosis of the disease; Results of thromboendarterectomy.
- Primary Pulmonary Hypertension Treated with Oral Phentolamine. Ruskin, Jeremy N.; Hutter Jr., Adolph M. // Annals of Internal Medicine;May79, Vol. 90 Issue 5, p772
Presents information on a study which evaluated the treatment trial of a patient with symptomatic primary pulmonary artery hypertension with parenteral and oral phentolamine. Information on primary pulmonary artery hypertension; Medical history of the patient; Results and discussion.